NFKB1 and atherosclerosis: Previous studies have reported that NF-κB inhibition by pyrrolidine dithiocarbamate (PDTC) negatively regulates inflammatory responses and lipid accumulation in macrophages induced by lipopolysaccharide (Feng et al. 2014; Luo et al. 2015), indicating a viable possibility for atherosclerosis prevention and therapy.